Eclipse Bioinnovations, Inc. (Eclipsebio), the leader in sequencing-based analytics and AI-enabled design for RNA therapeutics, today announced the launch of its eCOMPASS™ lab-in-the-loop platform, an ...
End-to-end RNA optimization: Platform combines proprietary AI sequence optimization, novel genetic parts, and lab validation in application-relevant cell models to improve expression and half-life, ...
BOSTON, March 19, 2026 (GLOBE NEWSWIRE)-- Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the launch of its RNA Edge System, an integrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results